Newsroom

The study proposes a large-scale workflow to produce natural killer cells and extracellular vesicles for cancer research & therapeutics.

Mild winter and early thaw part of changing climate trend that allows tick populations to survive and flourish in eastern Canada

A research team lead by Dr. Marisa Azad at The Ottawa Hospital has treated the first patient in Canada with bacteriophage (phage) therapy for a chronic artificial joint infection. Phages are viruses that prey on bacteria.

The rigorous study led by Canada Research Chair Dr. Arezu Jahani-Asl could have big implications for similar X-linked disorders that hobble the formation of new brain cells.

The Faculty has been a leader in prioritizing the health of the planet and working toward a sustainable future.

The University of Ottawa (uOttawa) has partnered with The Ottawa Hospital’s Biotherapeutics Manufacturing Centre and the Canadian Alliance for Skills and Training in Life Sciences (CASTL) to deliver a customized course as part of the university’s Microprogram in Biomanufacturing. Biomanufacturing is a rapidly growing industry that is critical for the production of new vaccines, gene therapies and ...

Preparations for the 91st annual ACFAS conference are well under way at the University of Ottawa, which is hosting the event from May 13 to 17 2024. The Honourable Michelle O’Bonsawin, the first Indigenous Supreme Court of Canada justice, will be serving as honorary president of the event, whose theme is knowledge mobilization in French.

More than ever, access to health care in French is a challenge for francophone minorities in Canada. Less than 1% of health-care professionals regularly speak French as part of their practice, according to a 2021 Statistics Canada study on language use in health care. Many francophones must therefore use their English to access health care.

University of Ottawa researcher develops bilingual healthcare app to help Canadians stay healthy in face of healthcare crisis

New research from the University of Ottawa proposes using vanoxerine as a safe method for potentially eliminating cancer stem cells in colorectal tumours